Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RPL5P1///RPL5P34///RPL5 |
| Upstream (Parents) |
|---|
| (<<) NKTR → RPL5P1///RPL5P34///RPL5 |
| (<<) TBC1D30 → RPL5P1///RPL5P34///RPL5 |
| (<<) DVL2 → RPL5P1///RPL5P34///RPL5 |
| (<<) EIF3J → RPL5P1///RPL5P34///RPL5 |
| Downstream (Children) |
|---|
| RPL5P1///RPL5P34///RPL5 → DDX43 (>>) |
| RPL5P1///RPL5P34///RPL5 → LOC100134331///LOC100126583///LOC652128///VSIG6///IGHV4-31///IGHM///IGHG4///IGHG3///IGHG1///IGHD///IGHA2///IGHA1///IGH@ (>>) |
| RPL5P1///RPL5P34///RPL5 → CD4 (>>) |
| RPL5P1///RPL5P34///RPL5 → PRAMEF12 (>>) |
| RPL5P1///RPL5P34///RPL5 → TTC39A (>>) |
| RPL5P1///RPL5P34///RPL5 → C1orf46 (>>) |
| RPL5P1///RPL5P34///RPL5 → HEXA (>>) |
| RPL5P1///RPL5P34///RPL5 → ATP9B (>>) |
| RPL5P1///RPL5P34///RPL5 → SH3BP2 (>>) |
